Hypercalcemia and acromegaly--clarifying the connections. A case report and review of the literature.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrine Practice

• Publication date

  2014-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP13228.CRPMID 24449661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vertebral fractures in patients with acromegaly: a 3-year prospective study.

  2013cited by this paper
• Role of the 1,25D3-MARRS receptor in the 1,25(OH)2D3-stimulated uptake of calcium and phosphate in intestinal cells.

  2012cited by this paper
• Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature

  2012cited by this paper
• Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption.

  2012cited by this paper
• Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D₃-enhanced duodenal calcium transport in male mice.

  2012cited by this paper
• Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?

  2012cited by this paper
• Expression and Immunolocalization of Calcium Transport Proteins in the Canine Duodenum, Kidney, and Pancreas

  2010cited by this paper
• Medical progress: Acromegaly.

  2006cited by this paper
• Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.

  2006cited by this paper
• Pathology of Acromegaly

  2006cited by this paper
• Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.

  2003cited by this paper
• Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.

  1998cited by this paper
• Insulin-like Growth Factor I, a Unique Calcium-dependent Stimulator of 1,25-Dihydroxyvitamin D3 Production

  1995cited by this paper
• Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity.

  1993cited by this paper
• Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport.

  1991cited by this paper
• Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I.

  1988cited by this paper
• Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.

  1985cited by this paper
• Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats.

  1984cited by this paper
• Calcium and vitamin D metabolism in acromegaly.

  1981cited by this paper
• Prolactin but not growth hormone stimulates 1,25-dihydroxyvitamin D3 production by chick renal preparations in vitro.

  1980cited by this paper
• The effect of elevated prolactin levels on plasma 1,25-dihydroxyvitamin D and intestinal absorption of calcium.

  1980cited by this paper
• The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans.

  1979cited by this paper
• Effect of growth hormone on vitamin D metabolism

  1978cited by this paper
• The effect of growth hormone on parathyroid function in rats.

  1976cited by this paper
• Calcium absorption and excretion in the gut in acromegaly

  1973cited by this paper
• Calcium Metabolism in Acromegaly

  1968cited by this paper
• Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man.

  1962cited by this paper

• Hypercalcémies extraparathyroïdiennes

  2024cites this paper
• The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study

  2023cites this paper
• Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment

  2022cites this paper
• Bone biochemical markers in acromegaly: An association with disease activity and gonadal status

  2022cites this paper
• Growth Hormone and IGF1 Actions in Kidney Development and Function

  2021cites this paper
• Renal effects of growth hormone in health and in kidney disease

  2021cites this paper
• Acromegaly and non‐parathyroid hormone‐dependent hypercalcemia: a case report and literature review

  2021cites this paper
• Disorders of calcium metabolism

  2021cites this paper
• Determinants of morbidities and mortality in acromegaly

  2019cites this paper
• Non-PTH-Mediated Hypercalcemia

  2019cites this paper
• Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.

  2018cites this paper
• Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study

  2017cites this paper
• Hypercalcemia Associated with Local and Ectopic Hormone Production

  2015cites this paper
• Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

  2014cites this paper
• Acromegaly and bone disease

  2014cites this paper